Italian Nanomedicine Platform

updated on 11 June 2026



AF.I FROM DISCOVERY TO TRANSLATION: INTEGRATING FAST-TRACK INNOVATION, ADVANCED DELIVERY SYSTEMS, AND DATA-DRIVEN PRECISION NANOMEDICINE *14 september*
The Italian Nanomedicine Platform (INP) brings its conversation to NanoInnovation 2026. On September 14^th, join the affiliated forum where science meets strategy and ideas move closer to real-world impact. Across four dedicated sessions, the forum will unite researchers, innovators, and industry stakeholders to cover the full nanomedicine innovation pipeline: Targeting, Delivery & Biomaterials Fast-Track Discovery, Early Tech Transfer & Advanced Characterisation Engineering, Late-Stage Tech Transfer & Regulatory Affairs Precision Nanomedicine, Omics & Data Integration Forum participants can submit a poster abstract for a dedicated INP poster session on September 14^th - and enjoy a 30% discount on submissions to the main NanoInnovation poster session. Registration fee: € 60 + VAT. To sign up and access the full programme, payment options, and submission guidelines, visit the dedicated page on the NanoItaly Association website: www.nanoitalyassociation.org
Chair: in definition
Co-organised with

This workshop, organised by the Italian Nanomedicine Platform, brings together leading researchers, innovators, and industry stakeholders in the field. The event highlights projects from platform members while fostering interaction with the broader scientific and economic ecosystem interested in nanomedicine. Renowned key speakers will provide high-level insights into current challenges and emerging opportunities. Covering the full innovation pipeline—from targeting and advanced delivery systems to tech transfer, scale-up, regulatory pathways, and data-driven precision approaches—the workshop offers a unique platform to connect discovery with real-world application and impact.


Session I Targeting, Delivery & Biomaterials 09:00 - 10:30
Chair: in definition
This session focuses on advanced strategies to enhance therapeutic performance through selective targeting, innovative drug delivery systems, and next-generation biomaterials. Emphasis will be placed on understanding bio–material interactions, including biodistribution, biocompatibility, and efficacy.
09:00 10:30	in definition
	in definition
	in definition
	in definition
10:30 - 11:00 break
Session II Fast-Track Discovery, Early Tech Transfer & Advanced Characterization 11:00 - 12:30
Chair: in definition
Dedicated to accelerating the path from fundamental research to early application, this session covers rapid screening technologies, advanced in vitro and in silico models, and cutting-edge characterization techniques. It also addresses early-stage tech transfer, from proof-of-concept to IP generation and valorization.
11:00 12:30	in definition
	in definition
	in definition
	in definition
12:30 - 14:00 lunch
Session III Engineering, Late-Stage Tech Transfer & Regulatory Affairs 14:00 - 15:30
Chair: in definition
This session explores the transition toward industrial and clinical implementation, including process engineering, scale-up, and standardization. Key topics include late-stage tech transfer, industry collaboration, and regulatory strategies such as EMA/FDA frameworks, Quality by Design, and clinical approval pathways.
PANELISTS
14:00 15:30	in definition
	in definition
	in definition
	in definition
	in definition
	in definition
15:30 - 16:00 break
Session IV Precision Nanomedicine, Omics & Data Integration 16:00 - 17:30
Chair: in definition
Focusing on data-driven and personalized approaches, this session highlights the integration of omics data and the use of AI and computational tools for target identification, nanomedicine optimization, and predictive modeling.
16:00 17:30	in definition
	in definition
	in definition
	in definition